Osiris Therapeutics said it has received approval from Health Canada to market its stem cell therapy Prochymal for the treatment of acute graft-vs-host disease in children.
Health care facilities are looking more and more toward temporary doctors to fill the vacancies from full-time physician shortages. Since full-time physicians are often highly stressed, more could appreciate the flexibility that a locum tenens career offers.
The market for Alzheimer’s drugs might be heating up soon as a number of companies are testing similar drugs to treat the disease. The expectation is that one of these drugs will have a huge payoff.
Two representatives are presenting a bill to do away with the flawed SGR formula, which dictates the annual cuts to Medicare reimbursement that Congress prevents on a yearly basis.
A new bill introduced in the House would make it mandatory for drug developers to publish all data, even negative results, from cancer clinical studies.